글작성시 입력했던 비밀번호를 입력해주세요.
| SHINE Medical Technologies Closes $150-million Series C-5 Financing | |
|---|---|
| WCI Secretariat Hit 1739 | 2021/08/04 |
|
SHINE Medical
Technologies LLC recently announced that it has closed the $150-million
financing for Series C-5. Koch Disruptive Technologies (KDT) led the round,
which also included participation from Fidelity Management & Research
Company, Baillie Gifford and other new and current investors. The financing
will support SHINE’s commercialization of its diagnostic and therapeutic medical
isotope technologies and position the company for future growth as it works
toward developing new fusion-based technology applications.
“SHINE’s mission is to usher in a new era of nuclear fusion technology and Koch, which is among the biggest players in energy, is a great long-term, strategic match enabling the pursuance our ultimate goal: fusion-based clean energy. “We are grateful for their confidence and investment in SHINE.” Greg Piefer, Chairman and CEO of SHINE said. To read more please visit: SHINE
Medical Technologies Closes $150-million Series C-5 Financing - SHINE Medical
Technologies |
|